Kurt Graves

Insider Reports History

Entity
Individual
Location
C/O Achillion Pharmaceuticals Inc., 300 George Street, New Haven, CT
Signature
/s/ Thomas J. DesRosier, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kurt Graves:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Seres Therapeutics, Inc. Director Stock Option (right to buy) 64.6K Jul 1, 2024 Direct

Insider Reports Filed by Kurt Graves

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MCRB Seres Therapeutics, Inc. Jul 1, 2024 1 $0 4 Jul 3, 2024 Director
MCRB Seres Therapeutics, Inc. Apr 4, 2024 1 $0 4 Apr 8, 2024 Director
MCRB Seres Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
MCRB Seres Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
MCRB Seres Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
MCRB Seres Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 21, 2021 Director